Wilhelm Leijonmarck

Artiklar

Article: GASTRIC CANCER. 2024;27(6):1180-1188
Survival among patients cured from gastric adenocarcinoma compared to the background population
Leijonmarck W; Mattsson F; Lagergren J
Article: GASTRIC CANCER. 2024;:1-6
Neoadjuvant chemotherapy in relation to long-term mortality in individuals cured of gastric adenocarcinoma
Leijonmarck W; Mattsson F; Lagergren J
Article: GASTRIC CANCER. 2024;27(3):590-597
Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study
Holmberg D; Kauppila JH; Asplund J; Leijonmarck W; Mattsson F; Lagergren J
Article: BJS OPEN. 2024;8(2):zrae015
Surgeon age in relation to patients' long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study
Leijonmarck W; Mattsson F; Asplund J; Markar S; Lagergren J
Article: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 2023;49(1):83-88
Weekday of gastrectomy and long-term survival in gastric adenocarcinoma
Leijonmarck W; Asplund J; Markar SR; Mattsson F; Lagergren J
Article: GASTRIC CANCER. 2022;25(3):652-658
Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma
Holmberg D; Kauppila JH; Mattsson F; Asplund J; Leijonmarck W; Xie S-H; Lagergren J
Article: ACTA ONCOLOGICA. 2021;60(4):513-520
Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS)
Asplund J; Gottlieb-Vedi E; Leijonmarck W; Mattsson F; Lagergren J